k**********4
发帖数: 16092 | 1 WASHINGTON (AP) — The Food and Drug Administration on Friday approved the
first drug to treat an unusual condition that causes painful, curved
erections in men.
The agency said it approved the biotech drug Xiaflex to treat Peyronie's
disease, which causes an abnormal bend in the penis during erection. The
disease is caused by scar tissue and can lead to pain and other difficulties
during sex.
FDA says the injectable drug is the first non-surgical treatment for the
disease.
Drugmaker Auxilium Pha... 阅读全帖 |
|
S*P
发帖数: 7575 | 2 interesting pick. thanks for sharing.
according to wiki, PD affects up to 10% of men and with limited treatments.
Xiaflex PII plan B data looks good (except that sample size is sort of small
):
The best results were achieved with a three-treatment series of three
injections each in Study B (n=10). In Study B, patients received three
injections of Xiaflex administered one per day, separated by at least one
day each, over a one-week timeframe. Patients received two additional series
of three injec... 阅读全帖 |
|
g****e
发帖数: 1426 | 3 Current price: $17
Catalyst evetn: Leerink Swann Global Healthcare Conference 2:30 p.m. ET on
Thursday, February 14, 2013
Its price is at Bottom with two more catalyst events:
1. Auxilium's drug Xiaflex for indication Frozen Shoulder Phase IIa. Top-
line data due in the first quarter of 2013.
2. Xiaflex indication for Dupuytren's disease have PDUFA on 09/06/2013.
Do your own DD before investing. Good luck!! |
|
g****e
发帖数: 1426 | 4 One correction:
Xiaflex indication for Peyronie's disease have PDUFA on 09/06/2013, NOT the
indication for Dupuytren's disease which is already approved.
AUXL's future is on the druge Xiaflex, more indications mean huge profit-up(
approved indication Dupuytren's plus going to approve indication Peyronie's
could mean more than $1B market opportunity without any notable competition)
. The other drug Testim could be challenged by generic.
AUXL is cash rich now, 173.49M + recent finance $338.7= abou... 阅读全帖 |
|
g****e
发帖数: 1426 | 5 Current price: $16.9
Catalyst evetn: Auxilium Pharmaceuticals, Inc. at Goldman Sachs Healthcare
Conference - 1:40PM EDT Jun 13, 2013
Its price is at Bottom with further big catalyst event:
Xiaflex indication for Peyronie's disease have PDUFA on 09/06/2013.
Also recent analyst updates:
Leerink upgraded Auxilium citing accretion from the Actient acquisition and
optimism for FDA approval of Xiaflex in Peyronie's disease. The firm raised
its price target for shares to $21 from $16.
Do your own DD be... 阅读全帖 |
|
d**b
发帖数: 1286 | 6 【 以下文字转载自 Sex 讨论区 】
发信人: dfbb (东方不败), 信区: Sex
标 题: Peyronie's disease
发信站: BBS 未名空间站 (Mon Dec 9 14:54:28 2013, 美东)
You may google pics for it. I saw many guys in porns have a curved penis
like this. Thought it is a gift. It turns out to be a painful disease?! FDA
just approved a drug for it.
http://www.fiercepharma.com/story/auxiliums-xiaflex-approved-tr |
|
y*****l
发帖数: 5997 | 7 http://stockcharts.com/scripts/php/candleglance.php?CHTP,ARNA,BIOD,VVUS,BVX,STAA|B|E12,26,9
从图上看，两个减肥药ARNA，VVUS和糖尿病BIOD今天都涨得不错; 低血压CHTP今天下跌
，原因是今天她的帕金森药被FDA通知进一步研究; 两个医疗器械中VVUS图形在底部刚
刚好，BVX还是下跌。欢迎大家补充，老牛和大胖给点药物分析。
12月所有药物FDA：
http://stockcharts.com/scripts/php/candleglance.php?CHTP,CEPH,ARNA,AUXL,BIOD,NVS,NVO,SHPGY,VVUS|B|E12,26,9
Adam的Biotech Calendar:
Chelsea Therapeutics(CHTP Quote)
Drug/indication: Droxidopa for neurogenic orthostatic hypotension
Outcome of FDA meeting to discuss changing pr... 阅读全帖 |
|
g******0
发帖数: 1165 | 8 Posted: 3/13/10 09:32
I will list all these targets mentioned by news:
Their top five candidates, based on their takeout target rankings, include
Vertex Pharmaceuticals (VRTX), as the Massachusetts-based company is close
to commercializing telaprevir, a potential blockbuster treatment for
hepatitis C.
“The company is building a diversified portfolio,” says Migliore. “The
company has no drugs on the market, and it has never been profitable. But it
has an $8 billion market cap because investors ar... 阅读全帖 |
|
g******0
发帖数: 1165 | 9 发信人: gucci320 (Cigdog), 信区: pennystock
标 题: 转个老帖~潜在被收购的医药公司名单-（希望大家发现宝藏）
发信站: BBS 未名空间站 (Thu May 6 10:58:19 2010, 美东)
Posted: 3/13/10 09:32
I will list all these targets mentioned by news:
Their top five candidates, based on their takeout target rankings, include
Vertex Pharmaceuticals (VRTX), as the Massachusetts-based company is close
to commercializing telaprevir, a potential blockbuster treatment for
hepatitis C.
“The company is building a diversified portfolio,” says Migliore. “The
compan... 阅读全帖 |
|
